Click here for our full Prescription Policy and Form
DRAXXIN is now the first-line product-of-choice to treat BRD, offering both superior disease treatment as well as outstanding efficacy for the control of BRD in cattle at high risk of developing the disease.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
100 mL vial treats 17–500 lb cattle or 8,770 lbs of cattle treated
- Do not use in female dairy cattle 20 months of age or older.
- Do not use in calves to be processed for veal. Effects on reproductive performance, pregnancy and lactation have not been determined.